LifeStance Health ROE 2020-2024 | LFST

Current and historical return on equity (ROE) values for LifeStance Health (LFST) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
LifeStance Health ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-12-31 $-0.06B $1.45B -3.97%
2024-09-30 $-0.10B $1.44B -6.64%
2024-06-30 $-0.15B $1.43B -10.52%
2024-03-31 $-0.17B $1.43B -11.91%
2023-12-31 $-0.19B $1.43B -12.64%
2023-09-30 $-0.19B $1.46B -12.59%
2023-06-30 $-0.16B $1.50B -10.84%
2023-03-31 $-0.19B $1.51B -12.35%
2022-12-31 $-0.22B $1.52B -14.11%
2022-09-30 $-0.28B $1.53B -18.01%
2022-06-30 $-0.36B $1.53B -23.30%
2022-03-31 $-0.36B $1.54B -23.31%
2021-12-31 $-0.34B $1.55B -24.55%
2021-09-30 $-0.24B $1.55B -19.04%
2021-06-30 $-0.12B $1.55B -14.07%
2021-03-31 $-0.09B $0.95B -17.42%
2020-12-31 $-0.04B $1.00B -15.23%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $2.275B $1.251B
LifeStance Health Group Inc. is provider of virtual and in-person outpatient mental health care for children, adolescents and adults of mental health conditions. LifeStance Health Group Inc. is based in SCOTTSDALE, Ariz.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.637B 19.35
Encompass Health (EHC) United States $11.786B 24.99
DaVita (DVA) United States $11.101B 15.33
Chemed (CHE) United States $8.326B 26.17
Elanco Animal Health (ELAN) United States $6.367B 13.64
Option Care Health (OPCH) United States $5.217B 23.25
RadNet (RDNT) United States $4.278B 271.57
Amedisys (AMED) United States $3.132B 21.06
Addus HomeCare (ADUS) United States $2.034B 22.33
Astrana Health (ASTH) United States $1.600B 39.64
U.S Physical Therapy (USPH) United States $1.175B 30.33
Aveanna Healthcare Holdings (AVAH) United States $1.128B 64.22
Pennant (PNTG) United States $1.019B 37.40
Atai Life Sciences (ATAI) Germany $0.288B 0.00
Daxor (DXR) United States $0.035B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
Psychemedics (PMD) United States $0.000B 0.00